Anemia, a condition characterized by a decrease in the number of red blood cells (RBCs) or less than the normal quantity of hemoglobin in the blood, presents a diagnostic challenge to healthcare professionals due to its multifactorial etiology. This guide aims to provide a systematic approach to the diagnosis of anemia.
The initial evaluation of anemia should involve a thorough patient history, physical examination, and basic laboratory tests. The history should focus on potential causes such as nutritional deficiencies, chronic diseases, or blood loss. The physical examination can provide clues to the etiology, such as pallor, jaundice, or signs of underlying diseases. Basic laboratory tests include complete blood count (CBC) and reticulocyte count.
The CBC provides information about the RBC count, hemoglobin level, and hematocrit. The mean corpuscular volume (MCV) can categorize anemia into microcytic, normocytic, or macrocytic, guiding further diagnostic steps. The reticulocyte count indicates the bone marrow response to anemia. A high reticulocyte count suggests increased RBC destruction or loss, while a low count indicates decreased RBC production.
Depending on the initial findings, further diagnostic tests may include iron studies, vitamin B12 and folate levels, hemoglobin electrophoresis, bone marrow biopsy, or tests for hemolysis. It's crucial to tailor these investigations based on the patient's history, physical examination, and initial laboratory results.
Anemia is a complex disorder with a myriad of causes. A systematic approach to its diagnosis, starting from a thorough history and physical examination, followed by initial laboratory tests and further tailored investigations, is essential for healthcare professionals. Understanding the pathophysiological basis of anemia and the interpretation of laboratory tests is key to unraveling the complexity of this condition.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation